β2-Microglobulin Amyloidosis in Chronic Dialysis Patients: A Case Report and Review of the Literature

Journal of the American Society of Nephrology

Volumn 8, Issue 3, 1997, Pages 509-514

  Farrell, John ^a   Bastani, Bahar ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTHRITIS; CARPAL TUNNEL SYNDROME; CASE REPORT; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; TIME;

AMYLOIDOSIS; ARTHRITIS; BETA 2-MICROGLOBULIN; CARPAL TUNNEL SYNDROME; FEMALE; HUMANS; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 0031093329     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Warren DJ, Otieno LS: Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J 51: 450-452, 1975
2. Geyjo F, Yamada T, Odani S, Nakagawa YM, Arakawa M, Kunitono T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K: A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129: 701-706, 1985
3. Van Ypersele De Strihou C, Jadoul M, Malghem J, Maldague B, Jamart L, and the Working Party on Dialysis Amyloidosis: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39: 1012-1019, 1991
4. Bardin T, Lebail-Darne JL, Zingraff J, Laredo JD, Voisin MC, Kreish H, Kuntz D: Dialysis arthropathy: Outcome after renal transplantation. Am J Med 99: 243-248, 1995
5. Linke RP, Bommer J, Ritz E, Waldherr R, Eulitz M: Amyloid kidney stones of uraemic patients consist of β2-microglobulin fragments. Biochem Biophys Res Commun 112: 665-671, 1986
6. Ogawa H, Saito A, Hirabayashi N, Hara K: Amyloid deposition in systemic organs in long term hemodialysis patients. Clin Nephrol 28: 199-204, 1987
7. 125I-labelled amyloid P component in β2m amyloidosis: A possible approach to quantitate disease activity. Nephrol Dial Transplant 10: 223-229, 1995
8. 123I-SAP scintigraphy [Abstract]. Nephrol Dial Transplant 9: 1017, 1994
9. Jadoul M, Malghem J, Van De Berg B, Van Ypersele De Strihou C: Ultrasonography of joint capsules and tendons in dialysis-related amyloidosis. Kidney Int 43[Suppl 41]: S106-S110, 1993
10. Connors LH, Shirahama T, Sipe JD, Skinner M, Fenves A, Cohen AS: Formation of amyloid fibrils from intact β2-microglobulin. Biochem Biophys Res Commun 131: 1063-1068, 1985
11. Ogawa H, Saito A, Oda O, Nakajima M, Chung TG: Detection of novel β2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition. Clin Nephrol 30: 158-163, 1988
12. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T: β2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92: 1243-1252, 1993
13. Vlassara H, Moldawer L, Chan B: Macrophage/monocyte receptor for nonenzymatically glycosylated proteins is upregulated by cachectin/tumor necrosis factor. J Clin Invest 84: 1813-1820 1989
14. Miyata T, Inagai R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of TNF and IL-1. J Clin Invest 93: 521-529, 1994
15. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG: An interleukin-1-like factor stimulates bone resorption in vitro. Nature (Lond) 306: 378-380, 1983
16. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (Lond) 319: 516-518, 1986
17. Homma N, Gejyo F, Isemura M, Arakawa M: Collagen-binding affinity of β2 microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 53: 37-40, 1989
18. Moe SM, Barrett SA, Sprague SM: β2-microglobulin stimulates osteoclastic mediated bone mineral dissolution from neonatal mouse calvariae. Calc Reg Hor Bone Metab 11: 302-306, 1992
19. Moe SM, Hack BK, Cummings SA, Sprague SM: Role of IL-1B and prostaglandins in β2-microglobulin-induced bone mineral dissolution. Kidney Int 47: 587-591, 1995
20. 125I-β2-microglobulin turnover in dialyzed patients. Kidney Int 42: 1434-1443, 1992
21. Campistol JM, Molina R, Rodriguez R, Munoz-Gomez J, Revert L: Dialysis membranes inhibit synthesis and release of β2-microglobulin in lymphocyte culture. Nephron 59: 691-692, 1991
22. Chanard J: Prevention of dialysis-related amyloidosis using the polyacrylnitrile AN69 membrane. Contrib Nephrol 112: 137-144, 1995
23. Brunner FP, Brynger H, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Case control study on dialysis arthropathy: The influence of two different dialysis membranes. Data from the EDTA registry. Nephrol Dial Transplant 5: 432-436, 1990
24. Canaud B, Assounga A, Kerr P, Angar R, Mion C: Failure of daily hemofiltration programme using highly permeable membrane to β2 microglobulin concentration to normal in hemodialysis patients. Nephrol Dial Transplant 7: 924-930, 1992
25. Bardin T: Low-dose prednisone in dialysis-related amyloid arthropathy. Rev Rhum Ed Fr 61: 97S-100S, 1994
26. Okutsu I, Ninomiya S, Takatori Y, Hamanaka I, Takemura T, Otsubo K, Otsubo O: Endoscopic management of shoulder pain in long-term hemodialysis patients. Nephrol Dial Transplant 6: 117-119, 1990.